Avastin Articles
Small number of combination drugs reaching the Japanese market
24 September 2007
Stock Commentary - New York week to Sept 10, 2007
17 September 2007
Erbitux meets Ph III NSCLC trial endpoints
17 September 2007
Japan stock market week to September 10, 2007
17 September 2007
Roche's Avastin cleared for NSCLC in EU
3 September 2007
Fast-track for Adventrx' ANX-510
3 September 2007
Japan stock market week to July 30, 2007
6 August 2007
CHMP recommends approval of Avastin for NSCLC
30 July 2007
UK cancer drug refusal "illegal" court told
23 July 2007
Japan stock market week to July 16, 2007
23 July 2007
Cancer, RA drugs boost Genentech
16 July 2007
Japan stock market week to June 18, 2007
25 June 2007
Japan's Chuikyo adds 13 NCEs to NHI list
18 June 2007
Japan stock market week to June 4, 2007
11 June 2007
Complete surveillance for Avastin in Japan
21 May 2007
New ABPI guideline for patient data published
21 May 2007
Roche's Avastin launched in the UK
21 May 2007
UK's NICE blamed for poor cancer care
21 May 2007
Japan stock market week to April 30, 2007
7 May 2007
Japan stock market week to April 23, 2007
30 April 2007
Antisoma reports promising preclinical data
23 April 2007
Roche's Avastin cleared in Japan for advanced CRC
23 April 2007
Stock Commentary - Europe - week to April 16, 2007
23 April 2007
Roche 1st-qtr at top end of expectations
23 April 2007
Japan stock market week to April 16, 2007
23 April 2007
Erbitux fails in Ph III pancreatic cancer trial
16 April 2007
EC expands indication for Roche's Avastin
9 April 2007
Roche submits new Xeloda regimen to FDA
2 April 2007
FDA fast-track for Nuvelo's rNAPc2
2 April 2007
Japan stock market week to March 5, 2007
12 March 2007
Drug spending in France rises 4%, flu blamed
5 March 2007
Japan stock market week to Feb 26, 2007
5 March 2007
Avastin gets tentative clearance in Japan
5 March 2007
Strong data for Avastin may lead to lower dose
5 March 2007
Roche posts record 2006 net profits, boosted by cancer drugs
12 February 2007
Stock Commentary - New York week to Jan 15, 2007
22 January 2007
Xeloda plus Avastin show clinical benefit
22 December 2006
Roche's Avastin is first drug to extend survival in patients with advanced NSCLC beyond one year
22 December 2006
Patient dosing begins in Ph II Davanat trial
11 December 2006
Lonza in two biomanufacturing deals with Genentech
13 November 2006
Roche reports sales of $23.89B for first three qtrs of 2006, a 4.7% share of global market
23 October 2006
Genentech's blockbuster Avastin gains new cancer indication; $2B sales predicted in 2007
23 October 2006
Genentech's 3rd-qtr GAAP net leaps 58%
16 October 2006
Less price flexibility, more innovation: the market dynamics of targeted therapeutics
16 October 2006
Stock Commentary - Europe - week to Oct 2, 2006
9 October 2006
Chugai to set up oncology unit
9 October 2006
Stock Commentary - Europe - week to Sept 18, 2006
25 September 2006
FDA requests new data on Genentech's Avastin
18 September 2006
Israeli cancer patients' hunger strike over drug access
18 September 2006
AS1411 shrinks relapsed patient's tumor
11 September 2006
Israeli basket update c'tee recommends another 16 new technologies
4 September 2006
Israeli NHI Ombudswoman's complaints report
4 September 2006
UK charities protest NICE bowel cancer ruling
28 August 2006
Off-label drug use defended by US think-tank
28 August 2006
New study validates Roche's XELOX in colorectal cancer
7 August 2006
Roche submits Avastin MAA to EMEA
17 July 2006
Genentech's Avastin misses Ph III endpoint
3 July 2006
Japan stock week to June 5
12 June 2006
Stock Commentary - New York week to May 29, 2006
5 June 2006
Genentech submits Avastin sBLA to US FDA
5 June 2006
Roche's 1st-qtr 2006 sales rise 22%
8 May 2006
Japan stock market week to April 24, 2006
1 May 2006
Chugai/Roche file Avastin in Japan
1 May 2006
Genentech submits Avastin NSCLC sBLA
17 April 2006
Stock Commentary - New York week to Feb 13, 2006
20 February 2006
Roche suspends Avastin AVANT study
20 February 2006
Strong data for metronomic chemo
19 December 2005
Licensing pivotal to pharma industry evolving strategies
19 December 2005
OXiGENE to initiate Ph Ib trial of CA4P combo
12 December 2005
Health Canada OKs colorectal cancer drugs
19 September 2005
Stock Commentary - Tokyo week to Aug 15
5 September 2005
Japan stock market two week to August 29
5 September 2005
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
